Acute kidney injury (AKI) is a clinical syndrome characterized by a rapid decline in renal
function, and is associated with a high risk of death. Many pathological changes happen in …

Currently, there are no clinical drugs available to treat acute kidney injury (AKI). Given the
high prevalence and high mortality rate of AKI, the development of drugs to effectively treat …

Acute kidney injury (AKI) is a serious clinical syndrome with high morbidity, elevated
mortality, and poor prognosis, commonly considered a “sword of Damocles” for hospitalized …

Acute kidney injury (AKI) is a clinical syndrome that results from a rapid decline in renal
structure or renal functional impairment with the main pathological feature of sublethal and …

Acute kidney injury (AKI), a major health issue concerning~ 50% of patients treated in
intensive care units, generally leads to severe renal damage associated with high mortality …

Cisplatin-induced acute kidney injury (CI-AKI) is a significant co-morbidity of
chemotherapeutic regimens. While this condition is associated with substantially lower …

Acute kidney injury (AKI) has been attracting increasing attention in recent years due to its
high mortality and highly associated with chronic kidney disease and end-stage kidney …

Acute kidney injury (AKI) is a serious kidney disease without specific medications currently
except for expensive dialysis treatment. Some potential drugs are limited due to their high …

Acute kidney injury (AKI) is frequently triggered by abundant reactive oxygen/nitrogen
species (RONS) and leads to high morbidity and mortality in clinic. Unfortunately, the current …

Acute kidney injury (AKI) is a common clinical syndrome with limited treatment options and
high mortality rates. Proximal tubular epithelial cells (PTECs) play a key role in AKI …